{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:11:24Z","timestamp":1790964684758,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04124-4","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T08:17:26Z","timestamp":1733300246000},"page":"1257-1266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype"],"prefix":"10.1007","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-5683","authenticated-orcid":false,"given":"Sara","family":"De Vincentis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Evangelisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Decaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Locaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ansaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-2164","authenticated-orcid":false,"given":"Elena","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-935X","authenticated-orcid":false,"given":"Antonello","family":"Pietrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-0696","authenticated-orcid":false,"given":"Vincenzo","family":"Rochira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"4124_CR1","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","volume":"350","author":"A Pietrangelo","year":"2004","unstructured":"A. Pietrangelo, Hereditary hemochromatosis\u2014a new look at an old disease. N. Engl. J. Med. 350, 2383\u20132397 (2004)","journal-title":"N. Engl. J. Med."},{"key":"4124_CR2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(15)01315-X","volume":"388","author":"LW Powell","year":"2016","unstructured":"L.W. Powell, R.C. Seckington, Y. Deugnier, Haemochromatosis. Lancet 388, 706\u2013716 (2016)","journal-title":"Lancet"},{"key":"4124_CR3","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, EASL Clinical Practice Guidelines on haemochromatosis. J. Hepatol. 77, 479\u2013502 (2022)","DOI":"10.1016\/j.jhep.2022.03.033"},{"key":"4124_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra2021838","volume":"384","author":"AT Taher","year":"2021","unstructured":"A.T. Taher, K.M. Musallam, M.D. Cappellini, \u03b2-Thalassemias. N. Engl. J. Med. 384, 727\u2013743 (2021)","journal-title":"N. Engl. J. Med."},{"key":"4124_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","volume":"391","author":"AT Taher","year":"2018","unstructured":"A.T. Taher, D.J. Weatherall, M.D. Cappellini, Thalassaemia. Lancet 391, 155\u2013167 (2018)","journal-title":"Lancet"},{"key":"4124_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.hoc.2017.11.006","volume":"32","author":"V Viprakasit","year":"2018","unstructured":"V. Viprakasit, S. Ekwattanakit, Clinical classification, screening and diagnosis for thalassemia. Hematol. Oncol. Clin. North Am. 32, 193\u2013211 (2018)","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"4124_CR7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","volume":"2017","author":"AT Taher","year":"2017","unstructured":"A.T. Taher, A.N. Saliba, Iron overload in thalassemia: different organs at different rates. Hematol. Am. Soc. Hematol. Educ. Program 2017, 265\u2013271 (2017)","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"4124_CR8","volume":"4","author":"P Brissot","year":"2018","unstructured":"P. Brissot, A. Pietrangelo, P.C. Adams, B. de Graaff, C.E. McLaren et al. Haemochromatosis. Nat. Rev. Dis. Prim. 4, 18016 (2018)","journal-title":"Nat. Rev. Dis. Prim."},{"key":"4124_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","volume":"358","author":"KJ Allen","year":"2008","unstructured":"K.J. Allen, L.C. Gurrin, C.C. Constantine, N.J. Osborne, M.B. Delatycki et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med. 358, 221\u2013230 (2008)","journal-title":"N. Engl. J. Med."},{"key":"4124_CR10","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","volume":"399","author":"A Kattamis","year":"2022","unstructured":"A. Kattamis, J.L. Kwiatkowski, Y. Aydinok, Thalassaemia. Lancet 399, 2310\u20132324 (2022)","journal-title":"Lancet"},{"key":"4124_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood-2018-02-830562","volume":"132","author":"K Sandhu","year":"2018","unstructured":"K. Sandhu, K. Flintoff, M.D. Chatfield, J.L. Dixon, L.E. Ramm et al. Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease. Blood 132, 101\u2013110 (2018)","journal-title":"Blood"},{"key":"4124_CR12","doi-asserted-by":"crossref","unstructured":"J.U. Hahn, M. Steiner, S. Bochnig, H. Schmidt, P. Schuff-Werner et al. Evaluation of a diagnostic algorithm for hereditary hemochromatosis in 3500 patients with diabetes. Diabetes Care 29, 464\u2013466 (2006)","DOI":"10.2337\/diacare.29.02.06.dc05-1417"},{"key":"4124_CR13","first-page":"dgz309","volume":"105","author":"WP Yang","year":"2020","unstructured":"W.P. Yang, H.H. Chang, H.Y. Li, Y.C. Lai, T.Y. Huang et al. Iron overload associated endocrine dysfunction leading to lower bone mineral density in thalassemia major. J. Clin. Endocrinol. Metab. 105, dgz309 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4124_CR14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00277-012-1412-7","volume":"91","author":"KM Belhoul","year":"2012","unstructured":"K.M. Belhoul, M.L. Bakir, M.S. Saned, A.M. Kadhim, K.M. Musallam et al. Serum ferritin levels and endocrinopathy in medically treated patients with \u03b2 thalassemia major. Ann. Hematol. 91, 1107\u20131114 (2012)","journal-title":"Ann. Hematol."},{"key":"4124_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/08880010801938207","volume":"25","author":"A Mehrvar","year":"2008","unstructured":"A. Mehrvar, A. Azarkeivan, M. Faranoush, N. Mehrvar, J. Saberinedjad et al. Endocrinopathies in patients with transfusion-dependent beta-thalassemia. Pediatr. Hematol. Oncol. 25, 187\u2013194 (2008)","journal-title":"Pediatr. Hematol. Oncol."},{"key":"4124_CR16","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3390\/diagnostics12081921","volume":"12","author":"M Carsote","year":"2022","unstructured":"M. Carsote, C. Vasiliu, A.I. Trandafir, S.E. Albu, M.C. Dumitrascu et al., New entity-thalassemic endocrine disease: major beta-thalassemia and endocrine involvement. Diagnostics 12, 1921 (2022)","journal-title":"Diagnostics"},{"key":"4124_CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-3476(79)80653-8","volume":"95","author":"JM Gertner","year":"1979","unstructured":"J.M. Gertner, A.E. Broadus, C.S. Anast, M. Grey, H. Pearson et al. Impaired parathyroid response to induced hypocalcemia in thalassemia major. J. Pediatr. 95, 210\u2013213 (1979)","journal-title":"J. Pediatr."},{"key":"4124_CR18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00198-005-1934-0","volume":"16","author":"P Guggenbuhl","year":"2005","unstructured":"P. Guggenbuhl, Y. Deugnier, J.F. Boisdet, Y. Rolland, A. Perdriger et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos. Int. 16, 1809\u20131814 (2005)","journal-title":"Osteoporos. Int."},{"key":"4124_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00043426-200205000-00014","volume":"24","author":"JP Chern","year":"2002","unstructured":"J.P. Chern, K.H. Lin, Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J. Pediatr. Hematol. Oncol. 24, 291\u2013293 (2002)","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"4124_CR20","first-page":"435","volume":"88","author":"V De Sanctis","year":"2018","unstructured":"V. De Sanctis, A.T. Soliman, D. Canatan, H. Elsedfy, M. Karimi et al. An ICET\u2014a survey on hypoparathyroidism in patients with thalassaemia major and intermedia: a preliminary report. Acta Biomed. 88, 435\u2013444 (2018)","journal-title":"Acta Biomed."},{"key":"4124_CR21","first-page":"324","volume":"10","author":"H Tangngam","year":"2018","unstructured":"H. Tangngam, P. Mahachoklertwattana, P. Poomthavorn, A. Chuansumrit, N. Sirachainan et al. Under-recognized hypoparathyroidism in thalassemia. J. Clin. Res. Pediatr. Endocrinol. 10, 324\u2013330 (2018)","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"4124_CR22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00774-005-0660-1","volume":"24","author":"NG Angelopoulos","year":"2006","unstructured":"N.G. Angelopoulos, A. Goula, G. Rombopoulos, V. Kaltzidou, E. Katounda et al. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J. Bone Min. Metab. 24, 138\u2013145 (2006)","journal-title":"J. Bone Min. Metab."},{"key":"4124_CR23","first-page":"35","volume":"70","author":"R Krysiak","year":"2013","unstructured":"R. Krysiak, B. Okopie\u0144, Hypoparathyroidism and hypogonadism as a clinical manifestation of hemochromatosis. Prz. Lek. 70, 35\u201337 (2013)","journal-title":"Prz. Lek."},{"key":"4124_CR24","doi-asserted-by":"crossref","unstructured":"Z. Shaheen, K. McCann, R.A. Khthir, SAT-354 isolated hypoparathyroidism: a rare initial manifestation of hereditary hemochromatosis (HH). J. Endocr. Soc. 4, SAT-354 (2020)","DOI":"10.1210\/jendso\/bvaa046.1886"},{"key":"4124_CR25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MED.0b013e3283591502","volume":"19","author":"V De Sanctis","year":"2012","unstructured":"V. De Sanctis, A. Soliman, B. Fiscina, Hypoparathyroidism: from diagnosis to treatment. Curr. Opin. Endocrinol. Diab. Obes. 19, 435\u2013442 (2012)","journal-title":"Curr. Opin. Endocrinol. Diab. Obes."},{"key":"4124_CR26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF03343916","volume":"24","author":"D Tiosano","year":"2001","unstructured":"D. Tiosano, Z. Hochberg, Endocrine complications of thalassemia. J. Endocrinol. Investig. 24, 716\u2013723 (2001)","journal-title":"J. Endocrinol. Investig."},{"key":"4124_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/eje.1.02316","volume":"156","author":"L Even","year":"2007","unstructured":"L. Even, T. Bader, Z. Hochberg, Nocturnal calcium, phosphorus and parathyroid hormone in the diagnosis of concealed and subclinical hypoparathyroidism. Eur. J. Endocrinol. 156, 113\u2013116 (2007)","journal-title":"Eur. J. Endocrinol."},{"key":"4124_CR28","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"D.M. Shoback, J.P. Bilezikian, A.G. Costa, D. Dempster, H. Dralle et al. Presentation of hypoparathyroidism: etiologies and clinical features. J. Clin. Endocrinol. Metab. 101, 2300\u20132312 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4124_CR29","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","volume":"98","author":"NE Cusano","year":"2013","unstructured":"N.E. Cusano, N.M. Maalouf, P.Y. Wang, C. Zhang, S.C. Cremers et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J. Clin. Endocrinol. Metab. 98, 2734\u20132741 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4124_CR30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/cen.12732","volume":"82","author":"A Palermo","year":"2015","unstructured":"A. Palermo, R. Jacques, F. Gossiel, D.M. Reid, C. Roux et al. Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study. Clin. Endocrinol. 82, 816\u2013823 (2015)","journal-title":"Clin. Endocrinol."},{"key":"4124_CR31","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/jbmr.4691","volume":"37","author":"AA Khan","year":"2022","unstructured":"A.A. Khan, J.P. Bilezikian, M.L. Brandi, B.L. Clarke, N.J. Gittoes et al. Evaluation and management of hypoparathyroidism summary statement and guidelines from the Second International Workshop. J. Bone Min. Res. 37, 2568\u20132585 (2022)","journal-title":"J. Bone Min. Res."},{"key":"4124_CR32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12020-020-02276-7","volume":"68","author":"B Madeo","year":"2020","unstructured":"B. Madeo, S. De Vincentis, A. Repaci, P. Altieri, V. Vicennati et al. The calcium-to-phosphorous (Ca\/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study. Endocrine 68, 679\u2013687 (2020)","journal-title":"Endocrine"},{"key":"4124_CR33","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"M.L. Brandi, J.P. Bilezikian, D. Shoback, R. Bouillon, B.L. Clarke et al. Management of hypoparathyroidism: summary statement and guidelines. J. Clin. Endocrinol. Metab. 101, 2273\u20132283 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4124_CR34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.amsu.2019.07.016","volume":"45","author":"H Majid","year":"2019","unstructured":"H. Majid, L. Jafri, S. Ahmed, J. Talati, B. Moiz et al. Unique classification of parathyroid dysfunction in patients with transfusion dependent thalassemia major using Nomogram\u2014a cross sectional study. Ann. Med. Surg. 45, 22\u201326 (2019)","journal-title":"Ann. Med. Surg."},{"key":"4124_CR35","doi-asserted-by":"crossref","unstructured":"Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin. Endocrinol. 42, 581\u2013586 (1995)","DOI":"10.1111\/j.1365-2265.1995.tb02683.x"},{"key":"4124_CR36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF03343575","volume":"22","author":"LM Hempenius","year":"1999","unstructured":"L.M. Hempenius, P.S. Van Dam, J.J. Marx, H.P. Koppeschaar, Mineralocorticoid status and endocrine dysfunction in severe hemochromatosis. J. Endocrinol. Investig. 22, 369\u2013376 (1999)","journal-title":"J. Endocrinol. Investig."},{"key":"4124_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00007611-197101000-00025","volume":"64","author":"OF Gabriele","year":"1971","unstructured":"O.F. Gabriele, Hypoparathyroidism associate with thalassemia. South Med. J. 64, 115\u2013116 (1971)","journal-title":"South Med. J."},{"key":"4124_CR38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12020-019-02159-6","volume":"69","author":"M Karimi","year":"2020","unstructured":"M. Karimi, T. Zarei, S. Haghpanah, A. Azarkeivan, C. Kattamis et al. Evaluation of endocrine complications in beta-thalassemia intermedia (\u03b2-TI): a cross-sectional multicenter study. Endocrine 69, 220\u2013227 (2020)","journal-title":"Endocrine"},{"key":"4124_CR39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5144\/0256-4947.2000.364","volume":"20","author":"A Aleem","year":"2000","unstructured":"A. Aleem, A.K. Al-Momen, M.S. Al-Harakati, A. Hassan, I. Al-Fawaz, Hypocalcemia due to hypoparathyroidism in beta-thalassemia major patients. Ann. Saudi Med. 20, 364\u2013366 (2000)","journal-title":"Ann. Saudi Med."},{"key":"4124_CR40","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12882-020-02101-3","volume":"21","author":"F Saki","year":"2020","unstructured":"F. Saki, A. Salehifar, S.R. Kassaee, G.R. Omrani, Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study. BMC Nephrol. 21, 482 (2020)","journal-title":"BMC Nephrol."},{"key":"4124_CR41","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s00198-016-3719-z","volume":"27","author":"AD Dede","year":"2016","unstructured":"A.D. Dede, G. Trovas, E. Chronopoulos, I.K. Triantafyllopoulos, I. Dontas et al. Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease. Osteoporos. Int. 27, 3409\u20133425 (2016)","journal-title":"Osteoporos. Int."},{"key":"4124_CR42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12882-020-01826-5","volume":"21","author":"F Saki","year":"2020","unstructured":"F. Saki, S.R. Kassaee, A. Salehifar, G.H.R. Omrani, Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients. BMC Nephrol. 21, 176 (2020)","journal-title":"BMC Nephrol."},{"key":"4124_CR43","doi-asserted-by":"crossref","first-page":"666","DOI":"10.20945\/2359-3997000000556","volume":"66","author":"NE Cusano","year":"2022","unstructured":"N.E. Cusano, F. Cetani, Normocalcemic primary hyperparathyroidism. Arch. Endocrinol. Metab. 66, 666\u2013677 (2022)","journal-title":"Arch. Endocrinol. Metab."},{"key":"4124_CR44","doi-asserted-by":"crossref","unstructured":"B. Madeo, S. De Vincentis, E. Kara, F. Vescini, T. Trenti et al. Reliability of calcium-phosphorus (Ca\/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca-P disorders. J. Endocrinol. Investig. 42, 1041\u20131049 (2019)","DOI":"10.1007\/s40618-019-01025-6"},{"key":"4124_CR45","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3390\/jcm11071826","volume":"11","author":"M Casale","year":"2022","unstructured":"M. Casale, M.I. Baldini, P. Del Monte, A. Gigante, A. Grandone et al. Good clinical practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the management of endocrine complications in patients with haemoglobinopathies. J. Clin. Med. 11, 1826 (2022)","journal-title":"J. Clin. Med."},{"key":"4124_CR46","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","volume":"115","author":"AT Taher","year":"2010","unstructured":"A.T. Taher, K.M. Musallam, M. Karimi, A. El-Beshlawy, K. Belhoul et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 115, 1886\u20131892 (2010)","journal-title":"Blood"},{"key":"4124_CR47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3324\/haematol.2020.272419","volume":"107","author":"M Casale","year":"2022","unstructured":"M. Casale, G.L. Forni, E. Cassinerio, D. Pasquali, R. Origa et al. Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort. Haematologica 107, 467\u2013477 (2022)","journal-title":"Haematologica"},{"key":"4124_CR48","volume":"14","author":"S De Vincentis","year":"2023","unstructured":"S. De Vincentis, G. Del Sindaco, A. Pagnano, G. Brigante, A. Moretti et al. Application of calcium-to-phosphorus (Ca\/P) ratio in the diagnosis of pseudohypoparathyroidism: another piece in the puzzle of diagnosis of Ca-P metabolism disorders. Front. Endocrinol. 14, 1268704 (2023)","journal-title":"Front. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04124-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:19:36Z","timestamp":1740147576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04124-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["4124"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04124-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the ethical standards of the Helsinki Declaration (1975, revised in 2013). The study protocol on Iron Overload and Endocrinological Diseases (n. CE 24\/13) was approved by the Local Ethical Committee of Modena in 2013 (ClinicalTrials.gov ID: NCT06137079) and all patients provided written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent has been obtained from each participant.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}